ENTERA BIO LTD. Public Float
ENTERA BIO LTD. (ENTX) had Public Float of $84.60 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $84.60M.
- 2024-06-30: Entity Public Float $58.80M.
- 2023-06-30: Entity Public Float $20.70M.
- 2022-06-30: Entity Public Float $32.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $84.60M 10-K · filed 2026-03-27 |
| 2024-06-30 | $58.80M 10-K · filed 2025-03-28 |
| 2023-06-30 | $20.70M 10-K · filed 2024-03-08 |
| 2022-06-30 | $32.90M 10-K · filed 2023-03-31 |
| 2021-06-30 | $142.10M 10-K/A · filed 2022-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |